354 Optimization of dose and regimen of letetresgene autoleucel for the treatment of synovial sarcoma: simulation of dose dependence and split dosing using quantitative systems pharmacology modeling

• Stefan Zajic,
• Galina Kolesova,
• Lourdes Cucurull-Sanchez

Affiliations

Stefan Zajic

1GlaxoSmithKline, Collegeville, PA, USA

Galina Kolesova

2InSysBio, Moscow, Russian Federation

Lourdes Cucurull-Sanchez

4GlaxoSmithKline, Stevenage, UK